Novo Nordisk CEO faces showdown with Bernie Sanders over drug prices

Global Banking and Finance Review is an online platform that provides news, analysis and opinions on the latest trends, developments and innovations in the global banking and finance sector. The platform covers a wide range of topics including banking, insurance, investments, wealth management, fintech and regulatory issues. The website publishes news, press releases, opinions and advertorials on various financial organisations, products and services commissioned by various companies, organisations, PR agencies, bloggers etc. These commissioned articles are commercial in nature. This is not to be considered financial advice and should be considered for information purposes only. It does not reflect the views or opinions of our website and is not to be considered an endorsement or recommendation. We cannot guarantee the accuracy or applicability of the information provided in relation to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate distribution networks and to the websites of our advertising partners. When you view or click on certain links available in our articles, our partners may compensate us for showing you the content or for making a purchase or completing a form. This is at no additional cost to you. To make it easier for you to identify or distinguish advertised or sponsored articles or links, you may consider any articles or links hosted on our website to be commercial article placement. We are not liable for any loss you incur as a result of any omissions or inaccuracies on the website.
.